The Journal of Clinical Psychiatry The Journal of Clinical Psychiatry

The Journal of
Clinical Psychiatry

Empowering mental health professionals with peer-reviewed psychiatric research and insights

Back to top Open menu arrow
Current Issue Archives Authors Reviewers

Page 19

More JCP Articles

JCP
Use of Medication With Depressive Symptom Side Effects
Original Research

May 24, 2023

MDD patients who used non-psychiatric medications with depressive side effects had higher odds of experiencing moderate to severe depressive symptoms.
, , , et al
JCP
Suicidal Ideation in Residential Substance Use Treatment
Original Research

May 22, 2023

People with substance use disorders (SUDs) and chronic health/psychiatric conditions may have higher risk for suicidal ideation than those with only SUD. Integrated treatments for patients with suicidal ideation…
, , , et al
JCP
Vortioxetine vs Desvenlafaxine in Patients With MDD
Original Research

May 22, 2023

Compared with desvenlafaxine, vortioxetine was associated with higher rates of symptomatic and functional remission, better daily and social functioning, and greater treatment satisfaction in patients with major depression and…
, , , et al
JCP
Predicting Remission From Depression in Youth Receiving Outpatient Medication Management
Original Research

May 17, 2023

Among 430 youth beginning treatment for depression, about one-quarter achieved remission within 6 months. The odds of remitting decreased as baseline symptom severity increased.
, , , et al
JCP
Cardiac Malformation Risks After First Trimester Methylphenidate Use
Brief Report

May 15, 2023

This meta-analysis found that use of methylphenidate in the first trimester may be a risk factor for fetal congenital heart defects.
, , , et al
JCP
Research Participant Feedback on a Suicide Safety Protocol
Original Research

May 15, 2023

In women who triggered a safety protocol as part of a perinatal suicidal ideation study, 50% reported that the protocol increased engagement with treatment, and most reported a “positive…
, , , et al
JCP
Control Conditions in Randomized Trials of Psychedelics: An ACTTION Systematic Review
Systematic Review

May 10, 2023

Randomized trials of psychedelics underutilize blind assessment, active drug controls, and testing psychological support against minimal-support conditions—elements that would improve quality or provide important information.
, , , et al
JCP
Depression Treatment Response Beyond 50% Improvement
Original Research

May 8, 2023

Although most depression treatment research focuses on symptom improvement, patients have additional treatment priorities, including functioning, coping ability, and quality of life.
,
JCP
Low Ghrelin and Anxiety in ARFID
Original Research

May 3, 2023

Low ghrelin levels were associated with greater anxiety in ARFID, indicating a potential target in the treatment of this disorder.
, , , et al
JCP
Endothelial Function in Youth With Bipolar Disorder
Original Research

May 1, 2023

Bipolar disorder (BD) confers risk for accelerated atherosclerosis and early cardiovascular disease. This study found that youth with BD have anomalous reactive hyperemia index (RHI)—a measure of endothelial function—which…
, , , et al
JCP
Abbreviated Suicide Crisis Syndrome Checklist and Decision Making in the ED
Original Research

May 1, 2023

The A-SCS-C had robust clinical utility and reduced clinicians’ reliance on patient-reported suicidal ideation to assess suicide risk in the ED setting.
, , , et al
JCP
rTMS for Treatment-Resistant Depression: Mismatch of Evidence and Insurance Coverage Policies
Commentary

April 26, 2023

The authors argue that insurance companies’ prior authorization process overly restricts access to rTMS, which has proven effectiveness for TRD.
, , , et al

Celebrating
85 Years

Read the Journal of Clinical Psychiatry

Subscribe to read
more articles

Subscribe